A Multicenter Randomized Double-blind Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents with Tourette
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The reason for this study is to find out the potential benefits and safety of aripirazole and compare it with a placebo in children and adolescents (ages 7-17) with Tourette?s disorder.
Description
The reason for this study is to find out the potential benefits and safety of aripirazole and compare it with a placebo in children and adolescents (ages 7-17) with Tourette?s disorder.
Details
| Condition | Tourettes Disorder |
|---|---|
| Age | 7years - 17years |
| Clinical Study Identifier | TX3007 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.